Momester (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momester, is a corticosteroid presented as a nasal spray for nasal administration. It is indicated for the management of allergic rhinitis, including both seasonal and perennial types, in adults and children when prescribed by a qualified healthcare professional. The formulation delivers a precise dose to the nasal mucosa, helping to reduce inflammation, congestion, and sneezing associated with allergen exposure.

GNH USA supplies Momester as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Momester, a nasal corticosteroid, is used to treat inflammatory conditions of the nasal passages.

Allergic rhinitis: alleviates nasal congestion, itching, and sneezing associated with allergic triggers. Seasonal allergic rhinitis: provides symptom relief during pollen and other seasonal allergen exposure. Perennial allergic rhinitis: controls year‑round nasal inflammation and related discomfort.

Mometasone furoate nasal spray may cause local and systemic adverse reactions, which are categorized by frequency.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleeds) - Throat irritation or dryness - Cough - Altered taste or bitter aftertaste

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or cataract formation - Adrenal suppression with prolonged high‑dose use - Opportunistic fungal infection of the nasal passages

When using Momester, several precautions should be observed to ensure safety and effectiveness.

Prescription use only: follow the healthcare provider's instructions and do not exceed the recommended dose. Not for use in children under 2 years: safety and efficacy have not been established in this age group. Avoid nasal trauma: do not insert the spray tip too far or apply excessive force. Monitor for signs of infection: report persistent nasal irritation, bleeding, or unusual discharge. Caution in patients with glaucoma or cataracts: glucocorticoids may increase intra‑ocular pressure. Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Mometasone furoate can interact with other medications, affecting its safety profile.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of adrenal suppression. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise systemic exposure to mometasone. - Live vaccines: immunosuppressive effect may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., fluconazole): may modestly increase mometasone levels. - Ritonavir and other protease inhibitors: potential for increased glucocorticoid exposure. - Other intranasal decongestants or steroids: may enhance local irritation or systemic effects.